A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for early symptomatic stages of the disease and availability of diagnostic tools providing patients with new hope.

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons. While we don’t fully understand the causes of PD, we know that risk factors may include head trauma, genetics, exposure to toxins and heavy metals, and other issues, such as a sedentary lifestyle.

Alzheimer’s disease is primarily caused by the buildup of amyloid plaques and neurofibrillary tangles in the brain, which disrupt communication between neurons and ultimately lead to their death. Remember,

Researches have helped in detecting the disease in early stages and drugs are now being made available for an effective and durable disease management, writes Vanita Srivastava.